SPRY4 and Kallmann syndrome: Summarized, these experiments demonstrated that in normal fibroblasts the investigated mutation found in Kallmann syndrome creates an altered Spry4 protein that is superior to the wt version in terms of its ability to inhibit ERK activation and the connected processes’ proliferation and migration.